The FDA clears Bristol Myers Squibb's (BMY +1.9%) ipilimumab, the first skin cancer drug that...

|By:, SA News Editor

The FDA clears Bristol Myers Squibb's (BMY +1.9%) ipilimumab, the first skin cancer drug that extends patients' lives and the first new drug for melanoma approved since 1998.